Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hae-Ki Min

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|October 20, 2017
The lignan manassantin is a potent and specific inhibitor of mitochondrial complex I and bioenergetic activity in mammalsYibao Ma, Hae-Ki Min, Unsong Oh, et al.
Molecules and Cells|December 4, 2003
Degranulation and cytokine expression in human cord blood-derived mast cells cultured in serum-free medium with recombinant human stem cell factorTae Chul Moon, Eunkyung Lee, Suk-Hwan Baek, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 10, 2015
Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver diseaseHae-Ki Min, Faridoddin Mirshahi, Aurora Verdianelli, et al.
Hepatology (Baltimore, Md.)|November 26, 2009
The plasma lipidomic signature of nonalcoholic steatohepatitisPuneet Puri, Michelle M Wiest, Onpan Cheung, et al.
Cell Chemical Biology|November 29, 2018
Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile AcidsJason D Kang, Christopher J Myers, Spencer C Harris, et al.
Hepatology (Baltimore, Md.)|November 1, 2020
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of SteatohepatitisBubu A Banini, Divya P Kumar, Sophie Cazanave, et al.
Scientific Reports|May 16, 2020
Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Scientific Reports|December 10, 2017
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Hepatology (Baltimore, Md.)|July 12, 2017
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acidsPuneet Puri, Kalyani Daita, Andrew Joyce, et al.
Hepatology (Baltimore, Md.)|May 13, 2022
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLDEkaterina Smirnova, Mark D Muthiah, Nicole Narayan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|October 20, 2017
The lignan manassantin is a potent and specific inhibitor of mitochondrial complex I and bioenergetic activity in mammalsYibao Ma, Hae-Ki Min, Unsong Oh, et al.
Molecules and Cells|December 4, 2003
Degranulation and cytokine expression in human cord blood-derived mast cells cultured in serum-free medium with recombinant human stem cell factorTae Chul Moon, Eunkyung Lee, Suk-Hwan Baek, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 10, 2015
Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver diseaseHae-Ki Min, Faridoddin Mirshahi, Aurora Verdianelli, et al.
Hepatology (Baltimore, Md.)|November 26, 2009
The plasma lipidomic signature of nonalcoholic steatohepatitisPuneet Puri, Michelle M Wiest, Onpan Cheung, et al.
Cell Chemical Biology|November 29, 2018
Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile AcidsJason D Kang, Christopher J Myers, Spencer C Harris, et al.
Hepatology (Baltimore, Md.)|November 1, 2020
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of SteatohepatitisBubu A Banini, Divya P Kumar, Sophie Cazanave, et al.
Scientific Reports|May 16, 2020
Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Scientific Reports|December 10, 2017
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Hepatology (Baltimore, Md.)|July 12, 2017
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acidsPuneet Puri, Kalyani Daita, Andrew Joyce, et al.
Hepatology (Baltimore, Md.)|May 13, 2022
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLDEkaterina Smirnova, Mark D Muthiah, Nicole Narayan, et al.
Pageof 4